ASX Announcement

Phase 1 IRX-616a Trial Advances to Final Cohort

Published: 28/04/26, 09:25am (AEST)2 pages
Nexalis Therapeutics
NX1:ASXHealthcare

Recent NX1 Announcements

Price Sensitive only